Nuzenio

Patient Dosed

Patient Dosed news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 13 publisher sources 100/100 entity strength

Latest news

First patient dosed in clinical study about stroke-related disability - Scientist LiveScientist Live · Fri, 07 Aug 2026 11:17:21 GMT First patient dosed with DISP-10 in Dispatch Bio’s cancer trial - YahooYahoo · Fri, 07 Aug 2026 09:47:43 GMT Theriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - clinicaltrialvanguard.comclinicaltrialvanguard.com · Fri, 07 Aug 2026 06:44:00 GMT Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 12:00:00 GMT Theriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock TitanStock Titan · Thu, 06 Aug 2026 12:00:00 GMT SystImmune doses first patient in Phase III trial for ES-SCLC - clinicaltrialsarena.comclinicaltrialsarena.com · Thu, 06 Aug 2026 10:25:17 GMT Migraine Biotech Doses First Patient in Phase 2b EVO756 Trial - Streetwise ReportsStreetwise Reports · Thu, 06 Aug 2026 09:41:48 GMT Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China - Banning Record GazetteBanning Record Gazette · Thu, 06 Aug 2026 00:00:00 GMT

Timeline

Fri, 07 Aug 2026 11:17:21 GMTFirst patient dosed in clinical study about stroke-related disability - Scientist Live

Fri, 07 Aug 2026 09:47:43 GMTFirst patient dosed with DISP-10 in Dispatch Bio’s cancer trial - Yahoo

Fri, 07 Aug 2026 06:44:00 GMTTheriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - clinicaltrialvanguard.com

Thu, 06 Aug 2026 12:00:00 GMTTheriva™ Biologics Announces First Patient Dosed in VIRAGE2 - GlobeNewswire

Thu, 06 Aug 2026 12:00:00 GMTTheriva’s Six-Patient Cancer Trial Is Designed to Test Repeat Virus Dosing - Stock Titan

Thu, 06 Aug 2026 10:25:17 GMTSystImmune doses first patient in Phase III trial for ES-SCLC - clinicaltrialsarena.com

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

Phase8 live mentions Trial7 live mentions Dosed6 live mentions First Patient Dosed6 live mentions Announces First Patient5 live mentions First4 live mentions First Patient3 live mentions GlobeNewswire GlobeNewswire3 live mentions DISP2 live mentions Dispatch Bio2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Patient Dosed.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

13 distinct publisher/source names are currently connected to this entity page.